| INTRODUC TI ON
Over the past 40 years, many randomized clinical trials (RCTs) have used composite endpoints when comparing medical interventions. [1] [2] [3] [4] These composite endpoints combine 2 or more clinically relevant endpoints, also known as the component endpoints (CEs), within a single outcome variable to measure clinical benefit of a treatment.
The conclusions of RCTs rely on their primary endpoints, and thus, it is important to choose the most appropriate endpoints when designing clinical research. 5 In recent years, medical care has significantly progressed for patients experiencing cardiovascular events, resulting in low mortality rates. Although death is still considered the primary outcome, it is often difficult for clinical researchers to identify differences in survival rates between the different treatment options. 6, 7 To investigate the occurrence of an infrequent event, large sample sizes, as well as prolonged follow-up, are needed, and costs go up. 8 When several adverse events are combined in a composite endpoint, the occurrence of events will increase, thereby expanding the overall treatment effect, and reducing the required sample size and overall costs of cardiovascular trials. 9, 10 Analytic approaches to composite endpoints generally assume that all underlying adverse events are of equal value. In practice, this assumption is rarely met, for instance: in some situations, the overall positive treatment effect may be related to "soft events" such as recurrent angina or redo revascularization as opposed to the clinically more relevant "hard" events such as major stroke or death. 11, 12 This heterogeneity of effect among CE can result in too optimistic conclusions about the treatment effect and serious misinterpretations. [13] [14] [15] One can account for these different effects by adjusting trial outcomes using "importance weights (values assigned to CE that reflect the relative importance of these CEs to patients)".
These "importance weights" are almost always derived through evaluations by an expert panel 11, 20 ; however, previous research has shown that patient and expert preferences towards CE are different 21 and thus cannot be considered equivalent. Therefore, the aim of this study was to examine patients' perspectives regarding the use of composite endpoints in clinical trials and the importance they attach to possible unfavourable outcomes of treatment. In addition, we examined whether the obtained "importance weights" differed between subgroups based on clinical and demographic characteristics of our study population. patients were included in this study 3-4 hours post-intervention.
| ME THODS

| Patient population
Patients who had a CABG procedure completed the survey on day 3 to 4 post-intervention. Patients who underwent CABG plus a surgical intervention to correct cardiac valve disease were not included in this study. In addition, patients who were unable to perform the study task correctly due to the cognitive burden the study posed or due to a language barrier were excluded. The study protocol was submitted to the regional medical-ethics committee (METC Twente, no. K16-45), but was deemed exempt from formal medical ethical evaluation, because the study does not fall within the remit of the Medical Research
Involving Human Subjects Act (WMO). 16 All patients provided written informed consent, and all data were anonymized before analysis.
The study complied with the Declaration of Helsinki. The literature provides no guidance to determine minimal required sample sizes for Best-Worst Scaling (BWS) experiments. To determine the minimum sample size needed, we used a rule of thumb for conjoint analysis which states that estimate precision increases rapidly at sample sizes over 150 and flattens out at around 300 observations. 17, 18 Taking into account the average number of patients undergoing a revascularization procedure throughout the 2-month study period, we aimed at including at least 150 patients.
| Patient preference survey
The original survey consisted of 4 different parts (Appendix S1). The PRECORE study started by asking patients to read the descriptions of the 8 CE examined in this study (Table 1) . After patients read the descriptions, they were asked to answer 4 statements about whether they thought it was equally important to prevent 2 complications (death vs disabling stroke; death vs disabling myocardial infarct (MI); death vs redo CABG; and disabling stroke vs disabling MI). The statements examined whether or not patients weigh the CE equally.
If patients answered at least one of these 4 statements with "yes, the avoidance of one of these 2 complications is more important to me, or they answered at least one of these 4 statements with "do not know," the relative importance of each complication (CE) was examined by means of 6 Best-Worst Scaling questions (BWS); the paragraph below explains this methodology. In addition to the preference elicitation questions, patients were asked for socio-demographics and clinical profile and one final question was asked to directly examine their view on the use of composite endpoints (Appendix S3).
The Web-based survey was programmed using LimeSurvey 19 and was intended for self-completion on a tablet. However, if patients indicated that they needed more explanation or assistance in completing the survey, assistance was given. On average, it took patients 30 minutes to answer the complete survey.
| Best-worst scaling: A method for determining the relative importance of CE to patients
The attributes included in this study were determined in a stepwise manner, which subsequently included a literature review, expert review and individual interviews with patients. First, a list of attributes that describe possible unfavourable outcomes of revascularization was compiled based on previously published literature. [21] [22] [23] [24] [25] [26] Second, this list of unfavourable outcomes was discussed within the steering committee of the research team (including 2 cardiologists with expertise in these interventions, and 2 senior health scientists for specialist methodological input). This expert review was conducted in order to (i) shorten the list of potential attributes and (ii) to ensure that the attributes were expected to be relevant for all patients who underwent a revascularization procedure. As a third step, 6 individual interviews were conducted with patients who underwent revascularization in order to ensure that (i) the most important attributes to patients were included and (ii) attribute descriptions were clear to patients. This process led to the inclusion of 8 attributes (Table 1 ).
The BWS method was used to determine the relative importance patients with CAD assign to the CE associated with coronary revascularization procedures. 27, 28 BWS is based on the random utility theory, which assumes that a patient's relative preference for characteristic A over characteristic B is a function of the relative frequency with which A is chosen as better than, or preferred to, B. 29, 30 This methodology was used, because it avoids and overcomes some of the limitations of rating-and ranking-based measurement methods. 27, 28 In BWS (case 1), respondents are asked to choose the best (eg least unfavourable) and worst items (eg most unfavourable) from a set of objects (ie adverse outcomes) 29 (Appendix S2). By presenting several of these set of objects to multiple patients, and studying the probability of patients choosing one objects over the other, the relative desirability of treat- Best-Minus-Worst counts were calculated to study the distribution of scores. Best and worst counts represent the number of times an attribute level was chosen as best or as worst across all choice-sets and respondents. 19 By subtracting the total number of times it was chosen as worst from the total number of times an outcome was chosen as best, an initial ranking of all 8 attributes from best (ie least unfavourable) to worst (ie most unfavourable) can be determined. To account for the number of times the attribute was available in the BWS design, normalized scores were calculated; that is, the Best-Minus-Worst counts (B-W counts) were divided by the sample size and the frequency that each attribute appeared in the design of the choice set.
As it was chosen to use data on the aggregated sample level, no statistical analysis can be performed to analyse the potential significance of these B-W counts. To explore potential heterogeneity in preferences between certain patient subgroups (gender, age, educational level, current revascularization procedure, previous revascularization experience and previous MI), several count analyses were performed.
P-values <.05 were considered statistically significant. 
| RE SULTS
| Patient inclusion
Of 176 patients contacted, 9 (5%) were excluded as they did not meet the inclusion criteria, 2 (1%) refused participation, and 5 (3%)
were discharged too early to participate. A total of 160 patients met the eligibility criteria, agreed to be surveyed and were included in the PRECORE study. Some patients received hands-on assistance by filling in the survey (n = 31, 19%) as they experienced physical constraint while filling in the survey. Another 6 (4%) patients received additional oral information and instructions after indicating a need for further assistance, and 9 (6%) patients received both hands-on assistance and additional oral information and instructions. The surveys of 13 (8.1%) patients were returned with incomplete BWSdata and could be not used for the analysis of the BWS-data.
| Patient characteristics
The patients' sociodemographic and treatment-related characteristics are presented in Table 2 . Of the 160 patients included in this study, a total of 97 (61%) underwent PCI and 63 (39%) were treated by CABG.
Patients were 67 ± 11 years old, and 120 (75%) were male. The majority of the respondents (n = 84, 52.5%) had a low level of education, and about a quarter (n = 40, 25%) was highly educated. A total of 86 (53.8%) patients had a previous MI, 9 (5.6%) a previous CABG, 45 (28.1%) a previous PCI and 5 (3.1%) experience with both PCI and CABG. A total of 105 patients (65.6%) had no history or previous coronary revascularization. Both patient groups had similar baseline profiles, but in line with clinical practice, significant differences were found between the PCI and CABG patients regarding the prevalence of diabetes (18.6% vs.
38.1%, P = .006, respectively) and previous revascularization (15.9% vs.
36.1%, P = .005, respectively).
| Statement data: Patients' perspective regarding CE differ
A vast majority of patients (n = 129, 80.6%) stated that the common practice of weighing all CE equally is invalid, and more than half of patients (n = 94, 58.8%) indicated that it is more important to prevent a major stroke causing permanent disability than death within 24 hours postintervention (Table 3) . Moreover, two-thirds of the patients (n = 126, 78.8%) reported that it is more important to prevent death within 24 hours post-intention than redo CABG. When patient's preferences of the CE were further analysed according to the patient's age, gender, previous MI or current type of revascularization procedure-no statistically significant differences were found (data not shown).
| BWS-data: Patients did not consider all CE equal
Systematic assessment by use of BWS showed that patients did not assign equal weights to all CE (Table 4 ). Figure 1 shows that patients considered the need to undergo a redo PCI within one year post-intervention the least unfavourable (importance weight: 0.008). Major stroke causing permanent disability was considered worse than death and all other CE (1.209). The preference data of patient subgroups are shown in Table 4 . The rank orders of most subgroups resemble the average estimate, except that highly educated patients (n = 36), females (n = 29), and elderly patients (n = 57) place greater emphasis on avoiding minor MI than recurrent angina. Furthermore, a notable difference was that highly educated patients (n = 36) valued death the most unfavourable outcome of this subset of outcomes, while the overall study population "preferred" death over disabling stroke.
| D ISCUSS I ON
The PRECORE study examined the patients' perspective regarding the use of composite endpoints and the utility patients put on pos- to patients. The current study and previous research in this field suggest that this is not the case. 11, 24 In accordance with previous recommendations, we therefore recommend using "weighted" CE, in which individual CEs a valued relative to one another. 11, 20, 22, 23, 25, 26, 36 Prior efforts to weigh these CE often assumed that patients, doctors and other experts would assign similar values to individual CEs; however, the study of Stolker et al. 21 showed that this is not the case. Where patients were most concerned about reducing MI or stroke, clinical trials placed greater emphasis on avoiding death. 21 Consequently,
we advise an alternative method that in concept is similar to the "weighted effect measure" methodology as stated by Armstrong et al. 20 In that methodology, the authors allocated weights that reflect the relative severity of individual CEs to patients; and the weights were determined through a clinician-investigator Delphi panel. 20 However, instead of experts assigning weights to CE, we suggest incorporating patient preferences in the evaluation of CEs. In addition, it is important to reach agreement on which method is most appropriate to measure patient preferences for adverse outcomes of treatment, such that normalized "importance weights" can be determined, and applied to raw trial data. Meanwhile, existing clinical trial data should be carefully interpreted, as these "non-weighted" data could be misleading.
| Strengths and limitations
This study has both strengths and limitations. To the best of our knowledge, this is one of the first studies that quantified the differences patients attributed to each CE using a choice-based method and to study whether or not patients agree with the scientific practice to combine multiple CE into one composite endpoint. The quantitative nature of this prospective, observational cohort study enables us to obtain insights into the distribution of preferences and the possible differences in these preferences between subgroups of patients. In addition, CE in this study are categorized according to severity and type of procedure (ie major/minor MI or stroke, and redo PCI/CABG). The present study has some limitations. First, we cannot exclude that the results of this single-centre study might be influenced by local clinical, geographical and socioeconomic factors, which limits generalization of the findings. Second, we cannot exclude that the views and priorities of patients, their physician and their family members, and their prior Data are n (%) or mean ± SD. CABG, coronary artery bypass grafting; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; MI, myocardial infarction; PCI, percutaneous coronary intervention. a 5 patients have had previous CABG and previous PCI. 37 Whether differences in these preferences are actually due to varying preferences, our somewhat broad brush CE descriptions, or might be better explained by varying levels of understanding the true ramifications of the different health outcomes should be further investigated.
TA B L E 2
Baseline characteristics of the study population (n = 160) (treatment) experiences may have driven preferences in this context. For instance, the obtained stated preferences reflect patients who
| CON CLUS IONS
The majority of patients in the PRECORE study indicated that they patients' preference and encourage a shift in thinking that may lead to importance weight-adjusted composite endpoints for clinical trials.
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